Norinchukin Bank The Boosts Stock Position in UnitedHealth Group Incorporated $UNH

Key Points

• Norinchukin Bank has increased its holdings in UnitedHealth Group by 13.5%, owning a total of 59,444 shares valued at approximately $31.13 million after purchasing an additional 7,069 shares in the first quarter.
• UnitedHealth Group recently missed earnings estimates for the quarter, reporting $4.08 EPS versus the consensus estimate of $4.45, despite a 12.9% revenue increase year-over-year.
• The company announced a quarterly dividend of $2.21, providing an annualized yield of 2.9%, which will be paid on September 23rd to investors of record on September 15th.

Norinchukin Bank The lifted its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.5% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 59,444 shares of the healthcare conglomerate's stock after purchasing an additional 7,069 shares during the period. Norinchukin Bank The's holdings in UnitedHealth Group were worth $31,134,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. CW Advisors LLC grew its holdings in shares of UnitedHealth Group by 44.3% in the first quarter. CW Advisors LLC now owns 31,136 shares of the healthcare conglomerate's stock worth $16,275,000 after purchasing an additional 9,564 shares during the last quarter. Summit Financial LLC grew its holdings in shares of UnitedHealth Group by 2.1% in the first quarter. Summit Financial LLC now owns 25,249 shares of the healthcare conglomerate's stock worth $13,224,000 after purchasing an additional 520 shares during the last quarter. Kaufman Rossin Wealth LLC bought a new position in shares of UnitedHealth Group in the first quarter worth approximately $438,000. PGIM Custom Harvest LLC grew its holdings in shares of UnitedHealth Group by 47.8% in the first quarter. PGIM Custom Harvest LLC now owns 5,600 shares of the healthcare conglomerate's stock worth $2,933,000 after purchasing an additional 1,812 shares during the last quarter. Finally, Fosun International Ltd lifted its stake in UnitedHealth Group by 5.9% in the first quarter. Fosun International Ltd now owns 5,157 shares of the healthcare conglomerate's stock worth $2,701,000 after acquiring an additional 289 shares during the period. Institutional investors own 87.86% of the company's stock.

Insider Activity

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.28% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Performance

NYSE UNH traded up $3.7480 during trading hours on Friday, hitting $307.0980. The company's stock had a trading volume of 14,867,565 shares, compared to its average volume of 23,516,492. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company's 50 day simple moving average is $288.39 and its two-hundred day simple moving average is $389.57. The company has a market cap of $278.13 billion, a P/E ratio of 13.31, a price-to-earnings-growth ratio of 1.96 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. HSBC reaffirmed a "reduce" rating and issued a $270.00 price target (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Wolfe Research dropped their price target on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a research note on Monday, May 19th. Bank of America raised their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research report on Monday. Finally, KeyCorp lowered their price objective on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $365.38.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.